M. Álvarez

Interethnic differences in the relevance of CYP2C9 genotype and environmental factors for diclofenac metabolism in Hispanics from Cuba and Spain

A. Llerena, E. Peñas-Lledó, P. Dorado, 2013, The Pharmacogenomics Journal.

CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans

A. Llerena, E. Peñas-Lledó, P. Dorado, 2010, The Pharmacogenomics Journal.

CYP2D6 -1584C>G promoter polymorphism and debrisoquine ultrarapid hydroxylation in healthy volunteers.

A. Llerena, E. Peñas-Lledó, P. Dorado, 2013, Pharmacogenomics.

Relation between CYP2D6 phenotype and genotype and personality in healthy volunteers.

A. Llerena, E. Peñas-Lledó, P. Dorado, 2008, Pharmacogenomics.

Preliminary CommuniCation Preliminary CommuniCation CYP 2 D 6-1584 C > G promoter polymorphism and debrisoquine ultrarapid hydroxylation in healthy volunteers

A. Llerena, E. Peñas-Lledó, M. Naranjo, 2010 .

[Study of debrisoquine hydroxylation polymorphism (CYP2D6) in the Cuban population compared to Spaniards].

A. Llerena, P. Dorado, I. González, 2007, Medicina clinica.